GlassScriptPhysician profile
James V Waldron
NPI 1215054853
$6,862.73
in general payments reported to CMS, 2019-2025
36 companies · $2,240 in 2025
The $2,240 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $637 · 2022: $912 · 2023: $1,119 · 2024: $1,955 · 2025: $2,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,274 · Education: $39.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,274.07 |
| Education | $39.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $912.56 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $793.14 | 2021-2025 | Tezspire, Airsupra, Fasenra |
| Genzyme Corporation | $688.83 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $669.30 | 2021-2025 | |
| Grifols USA, LLC | $540.77 | 2021-2025 | Prolastin-C Liquid, Xembify |
| Boehringer Ingelheim Pharmaceuticals, INC. | $338.93 | 2021-2024 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Regeneron Healthcare Solutions, INC. | $270.93 | 2022-2025 | Dupixent |
| Harmony Biosciences LLC | $244.85 | 2025 | |
| Baxter Healthcare | $208.02 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Insmed, INC. | $191.10 | 2021-2025 | Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $178.56 | 2023-2025 | Cuvitru, Glassia |
| Axsome Therapeutics, INC. | $177.82 | 2024-2025 | Sunosi |
| Actelion Pharmaceuticals US, INC. | $175.33 | 2023-2025 | Opsumit, Uptravi, Opsynvi |
| Avadel Cns Pharmaceuticals, LLC | $156.59 | 2024-2025 | Lumryz |
| Viatris Specialty LLC | $141.33 | 2025 | Yupelri |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $134.49 | 2021-2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $122.06 | 2022-2025 | Acthar |
| Amgen INC. | $111.78 | 2024-2025 | Tezspire |
| Bayer Healthcare Pharmaceuticals INC. | $102.23 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $96.50 | 2022 | |
| Inspire Medical Systems, INC. | $78.19 | 2025 | Inspire |
| Resmed Corp | $65.27 | 2023-2025 | |
| United Therapeutics Corporation | $63.60 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $55.27 | 2022-2023 | Belsomra |
| Pfizer INC. | $54.05 | 2023-2024 | |
| Covis Pharma Gmbh | $51.68 | 2021-2022 | |
| 3b Medical, INC. | $49.36 | 2024 | Luna |
| Ani Pharmaceuticals, INC. | $32.47 | 2023-2024 | Purified Cortrophin Gel |
| Vapotherm INC | $26.75 | 2022 | |
| Noctrix Health, INC. | $26.59 | 2025 | Nidra |
| Vifor Pharma, INC. | $22.82 | 2024 | Zemaira |
| Csl Behring | $20.77 | 2021 | |
| Optinose US, INC. | $16.65 | 2021 | |
| Azurity Pharmaceuticals, INC. | $16.35 | 2025 | Alvesco |
| Lilly USA, LLC | $14.33 | 2025 | Zepbound |
| Olympus America INC. | $13.46 | 2023 | Spiration Valve System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Waldron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.